Cure for malaria

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

· Novartis and Medicines for Malaria Venture (MMV) announce decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria · This novel combination also contains an optimized formulation of

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Cure for malaria

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

Featured Stories

Fuel Subsidy: World Bank Must Allow Africa’s Poor Breathe [Editorial]

Survey: 65.8% Respondents Want Interest Rate Cut As CBN Holds MPC Meeting

Dangote’s Frequent Price Cuts And Ripples Of Intense Competition In Nigerian Fuel Market

BBNaija Season 9: See Full Housemates, Pairs List

Latest News

Court Strikes Down Trump’s Tariffs as Illegal Overreach, Sets Stage for Supreme Court Battle

Will The CBN’s New Rule Stop POS Fraud?

Naira Records Marginal Gain As External Reserves Hit $41.27bn In August

GTCO Bolsters GTBank With N365.85 Billion Injection, Secures International Licence

APC Campaign Council

Categories

Suggestions

Cure for malaria

Follow Us

Featured Stories

Latest News

APC Campaign Council

Categories